CoChat

Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer

Open access
Lin, Tong, Qiu, Yuqin, Peng, Wenya, Peng, Lisheng · 2020 · BioMed Research International

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Background. The heat shock protein 90 (HSP90s) family is composed of molecular chaperones composed of four isoforms in humans, which has been widely reported as unregulated in various kinds of cancers. Nevertheless, the role of each HSP90s isoform in prognosis and immune infiltration in distinct subtypes of breast cancer (BRAC) remains unclear. Methods. Public online databases including the Oncomine, UALCAN, Kaplan‐Meier Plotter, Tumor IMmune Estimation Resource (TIMER), Gene Expression Profiling Interactive Analysis (GEPIA), GeneMANIA, and Database for Annotation, Visualization, and Integrated Discovery (DAVID) were integrated to perform bioinformatic analyses and to explore the possible associations among HSP90s gene expression, prognosis, and immune infiltration in BRAC. Results. The mRNA expression of all HSP90s members was elevated in distinct clinical stages and subtypes of BRAC, compared with the normal breast tissue (P < 0.05). Overexpressed HSP90AA1 was associated with poor prognosis, particularly, both short overall survival (OS) and release‐free survival (RFS) in Basal‐like BRAC patients; overexpressed HSP90AB1 and HSP90B1 were both associated with poor RFS in Luminal A BRAC patients, while overexpressed TRAP1 was associated with favorable RFS in Luminal A BRAC patients. Moreover, HSP90s gene expression in BRAC showed correlations with the infiltration of CD8+ T cells, neutrophils, macrophages, and dendritic cells (DCs), as well as the activation of tumor‐associated macrophages (TAMs), DCs, and CD4+ helper T (Th) cells. The underlying mechanisms of HSP90s modulating tumor‐infiltrating immune cells (TIICs) might be related with their functions in antigen processing and presentation, major histocompatibility complex (MHC) binding, and assisting client proteins. Conclusion. This study demonstrated that HSP90s family genes were overexpressed and might be serve as prognostic biomarkers in subtypes of BRAC. It might be a novel breakthrough point of BRAC treatment to regulate immune infiltration in BRAC microenvironment for more effective anticancer immunity through pharmacological intervention of HSP90s.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2020/2148253

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Transcriptional expression of HSP90s isoforms in various kinds of human cancers and BRAC. (a) Transcriptional expression of HSP90s isoforms in various kinds of cancers (the Oncomine). Notes: number in the colored cell is equal to the number of datasets with statistically significant HSP90s mRNA up expression (red) or down expression (blue), compared with the corresponding normal samples. Color depth represents a median rank of a gene, across all the included analyses. (b) Transcriptional expression of HSP90s isoforms in BRAC, compared with the normal breast tissues (the UALCAN) (∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001).
Figure 1 Transcriptional expression of HSP90s isoforms in various kinds of human cancers and BRAC. (a) Transcriptional expression of HSP90s isoforms in various kinds of cancers (the Oncomine). Notes: number in the colored cell is equal to the number of datasets with statistically significant HSP90s mRNA up expression (red) or down expression (blue), compared with the corresponding normal samples. Color depth represents a median rank of a gene, across all the included analyses. (b) Transcriptional expression of HSP90s isoforms in BRAC, compared with the normal breast tissues (the UALCAN) (∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001).CC BY · PubMed Central
Figure 2 Expression of HSP90s genes in BRAC by clinicopathological stages and intrinsic subtypes (the UALCAN). Expression of HSP90AA1, HSP90AB1, HSP90B1, and TRAP1 in BRAC classified by (a) clinicopathological stages and (b) intrinsic subtypes (∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001).
Figure 2 Expression of HSP90s genes in BRAC by clinicopathological stages and intrinsic subtypes (the UALCAN). Expression of HSP90AA1, HSP90AB1, HSP90B1, and TRAP1 in BRAC classified by (a) clinicopathological stages and (b) intrinsic subtypes (∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001).CC BY · PubMed Central
Figure 3 Prognostic significance of HSP90s genes in all BRAC patients (the KM Plotter). The Kaplan-Meier plots showed the associations between the HSP90s gene expression with OS and RFS in all BRAC patients. Note: Affymetrix IDs for HSP90AA1, HSP90AB1, HSP90B1, and TRAP1 were “214328_s_at,” “200064_at,” “200599_s_at,” and “221235_s_at,” respectively. P < 0.05 was thought as significant. Abbreviations: OS: overall survival; RFS: relapse-free survival; HR: hazard ratio.
Figure 3 Prognostic significance of HSP90s genes in all BRAC patients (the KM Plotter). The Kaplan-Meier plots showed the associations between the HSP90s gene expression with OS and RFS in all BRAC patients. Note: Affymetrix IDs for HSP90AA1, HSP90AB1, HSP90B1, and TRAP1 were “214328_s_at,” “200064_at,” “200599_s_at,” and “221235_s_at,” respectively. P < 0.05 was thought as significant. Abbreviations: OS: overall survival; RFS: relapse-free survival; HR: hazard ratio.CC BY · PubMed Central
Figure 4 Prognostic significance of HSP90s genes in BRAC patients with different clinical parameters. Note: forest plots showed HR and 95% CI of the univariate survival analyses; the results with statistical significance are in bold. The data of RFS in the fourth stage of BRAC patients could not be analyzed due to the insufficient sample size. Abbreviations: OS: overall survival; RFS: relapse-free survival; HR: hazard ratio; CI: confidence interval.
Figure 4 Prognostic significance of HSP90s genes in BRAC patients with different clinical parameters. Note: forest plots showed HR and 95% CI of the univariate survival analyses; the results with statistical significance are in bold. The data of RFS in the fourth stage of BRAC patients could not be analyzed due to the insufficient sample size. Abbreviations: OS: overall survival; RFS: relapse-free survival; HR: hazard ratio; CI: confidence interval.CC BY · PubMed Central
Figure 5 Correlations of HSP90s gene expression with immune infiltration in BRCA. (a) Correlations of HSP90s gene expression with tumor purity and infiltration of B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and DCs in all BRCA (the TIMER). (b) Heat maps show the correlations of HSP90s gene expression with immune filtration in subtypes of BRCA. Note: correlation coefficients with statistical significance are shown in bold; red or blue color represents positive or negative correlations, respectively. Abbreviations: B: B cells; CD4: CD4+ T cells; CD8: CD8+ T cells; N: neutrophils; mø: macrophages; DC: dendritic cells.
Figure 5 Correlations of HSP90s gene expression with immune infiltration in BRCA. (a) Correlations of HSP90s gene expression with tumor purity and infiltration of B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and DCs in all BRCA (the TIMER). (b) Heat maps show the correlations of HSP90s gene expression with immune filtration in subtypes of BRCA. Note: correlation coefficients with statistical significance are shown in bold; red or blue color represents positive or negative correlations, respectively. Abbreviations: B: B cells; CD4: CD4+ T cells; CD8: CD8+ T cells; N: neutrophils; mø: macrophages; DC: dendritic cells.CC BY · PubMed Central
Figure 6 Functions of HSP90s interaction network. (a) The gene interaction network of HSP90s constructed by the GeneMANIA. Note: distinct colors of the network edges represent the distinct bioinformatic methods applied: physical interactions, coexpression, predicted, colocalization, pathway, genetic interactions, and shared protein domains. Distinct colors of the network nodes represent the biological functions of the sets of genes. (b) The results of GO enrichment analysis: the top five terms of BP and MF and all terms of CC are shown. (c) The results of KEGG enrichment analysis: all KEGG terms are shown.
Figure 6 Functions of HSP90s interaction network. (a) The gene interaction network of HSP90s constructed by the GeneMANIA. Note: distinct colors of the network edges represent the distinct bioinformatic methods applied: physical interactions, coexpression, predicted, colocalization, pathway, genetic interactions, and shared protein domains. Distinct colors of the network nodes represent the biological functions of the sets of genes. (b) The results of GO enrichment analysis: the top five terms of BP and MF and all terms of CC are shown. (c) The results of KEGG enrichment analysis: all KEGG terms are shown.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

Metadata

Authors
Lin, T., Qiu, Y., Peng, W., & Peng, L.
Affiliations
  • Guangzhou University of Chinese Medicine (CN)
  • Shenzhen Traditional Chinese Medicine Hospital (CN)
Corresponding author
Peng, Lisheng
Venue
BioMed Research International
Publisher
Wiley
Published
2020-01
Volume
2020
Issue
1
Pages
2148253-2148253
ISSN
  • 1110-7243 (ISSN-L)
  • 2314-6133
  • 2314-6141
OpenAlex
W3094633644
Cited by
31
References
57
Citations by year
2026: 2 · 2025: 3 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 3
FWCI
1.54
Type
journal article
Language
en
Open access
Locations
  • BioMed Research International (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
HSP90, Hsp90 isoforms, HSP90AA1, HSP90AB1, HSP90B1, TRAP1, breast cancer, prognostic factors, tumor immune infiltration, tumor microenvironment, basal-like breast cancer, luminal A, CD8+ T cells, tumor-associated macrophages, dendritic cells, neutrophils, antigen processing and presentation, MHC binding, overall survival, recurrence-free survival
MeSH terms
Tumor-Associated Macrophages, Atlases as Topic, Breast Neoplasms, Adenocarcinoma, Mucinous, Cell Movement, Dendritic Cells, Female, Humans, Membrane Glycoproteins, Neoplasm Invasiveness, Prognosis, Biomarkers, Tumor, CD4-Positive T-Lymphocytes, Gene Expression Regulation, Neoplastic, Carcinoma, Lobular, CD8-Positive T-Lymphocytes, HSP90 Heat-Shock Proteins, Computational Biology, Databases, Genetic, Carcinoma, Ductal, Molecular Sequence Annotation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.